NEW YORK (GenomeWeb) – ThermaGenix has completed a $1.5 million series A-1 financing round.

The Waltham, Massachusetts-based firm, which brands itself "the PCR Improvement Company," said it will use some of the funds to support commercial activities related to its ThermaStop and ThermaGo products — PCR additive reagents that improve polymerase fidelity and product purity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.